Malalis, Myla .
HRN: 11-66-32 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2025
CEFUROXIME 1.5GM (VIAL)
12/13/2025
12/13/2025
IV
1.5g
PTOR
Elective Cs
Checking Final Appropriateness
12/13/2025
CEFUROXIME 500MG (TAB)
12/13/2025
12/20/2025
PO
500mg
BID
S/P LTCS W/ BTL
Checking Final Appropriateness
12/13/2025
METRONIDAZOLE 500MG (TAB)
12/13/2025
12/20/2025
PO
500mg
TID
S/P LTCS
Checking Final Appropriateness